Abacavir, lamivudine, and zidovudine and Risankizumab-rzaa topical
Determining the interaction of Abacavir, lamivudine, and zidovudine and Risankizumab-rzaa topical and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: abacavir / lamivudine / zidovudine
Brand name: Trizivir
Synonyms: Abacavir, Lamivudine, and Zidovudine
Generic Name: risankizumab
Brand name: Skyrizi
Synonyms: Risankizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abacavir, lamivudine, and zidovudine-Risedronate
- Abacavir, lamivudine, and zidovudine-Risedronate and Calcium
- Abacavir, lamivudine, and zidovudine-Risedronate Delayed Release
- Abacavir, lamivudine, and zidovudine-Risedronate Delayed-Release Tablets
- Abacavir, lamivudine, and zidovudine-Risedronate Sodium
- Abacavir, lamivudine, and zidovudine-Risedronate Tablets
- Risankizumab-rzaa topical-Abaloparatide
- Risankizumab-rzaa topical-Abaloparatide Subcutaneous
- Risankizumab-rzaa topical-Abatacept
- Risankizumab-rzaa topical-Abatacept Auto-Injectors
- Risankizumab-rzaa topical-Abatacept Infusion
- Risankizumab-rzaa topical-Abatacept Intravenous